Abingdon Health Plc
Abingdon Health Plc (ABDXF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
abdxf · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Abingdon Health Plc (ABDXF) measures how much investors pay for each dollar of the company's trailing earnings. ABDXF's current PE ratio of N/A is calculated by dividing its stock price of $0.17 by its TTM earnings per share of -$0.01.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Abingdon Health PlcYou ABDXF | $32M | N/A | — | -$0.01 |
 Ceapro Inc. CRPOF | $13M | N/A | — | -$0.06 |
 Eiger BioPharmaceuticals, Inc. EIGRQ | $13M | N/A | — | -$50.78 |
 Nurosene Health Inc. MNNDF | $14M | N/A | — | — |
 Noxopharm Limited NOXOF | $15M | N/A | — | -$0.01 |
 Poxel S.A. PXXLF | $16M | N/A | — | -$0.43 |
 RAMM Pharma Corp. RAMMF | $15M | N/A | — | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $-0.01 | — | |
2024-06-30 FY2024 | — | $-0.00 | — | |
2023-06-30 FY2023 | — | $-0.01 | — | |
2022-06-30 FY2022 | — | $-0.07 | — | |
2021-06-30 FY2021 | — | $-0.07 | — | |
2020-06-30 FY2020 | — | $-0.04 | — | |
2019-06-30 FY2019 | — | $-0.01 | — | |
2018-06-30 FY2018 | 1.47x | $0.04 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Abingdon Health Plc (ABDXF) measures how much investors pay for each dollar of the company's trailing earnings. ABDXF's current PE ratio of N/A is calculated by dividing its stock price of $0.17 by its TTM earnings per share of -$0.01.
Frequently asked questions
ABDXF pe ratio · 6 questionsABDXF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.17 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via ABDXF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Abingdon Health Plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09